Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

49 evidence items · page 1 / 2

12.61 %The prevalence of hepatitis B virus infection in HIV-positive persons in Burkina Faso was 12.61% after adjustment.

Burkina Fasohépatite Bpublished 2018BMC public healtheurope_pmcdocument of 12 observationsDOI 10.1186/s12889-018-5432-7

17 %Trois des 18 cas positifs pour le virus de l'hépatite B étaient âgés de moins de 15 ans, soit 17 %.

Burkina Fasohépatite BHAL · Unilimdocument of 26 observations

18 casL'hépatite B a été détectée dans 18 cas sur l'ensemble des échantillons analysés par mNGS.

Burkina Fasohépatite BHAL · Unilimdocument of 26 observations

16 %Median HBsAg prevalence was approximately 16% in male blood donors in Burkina Faso.

Burkina Fasohépatite Bpublished 2022Viruseseurope_pmcdocument of 11 observations

14.66 %The prevalence of hepatitis B virus infection in the Boucle du Mouhoun region of Burkina Faso was 14.66%.

Burkina Fasohépatite Bpublished 2018BMC public healtheurope_pmcdocument of 12 observationsDOI 10.1186/s12889-018-5432-7

29.4 %The prevalence of HBsAg was 29.4% among the 462 screened patients at Saint Camille Medical Centre.

Burkina Fasohépatite Bobserved 2012published 2012Pakistan journal of biological sciences : PJBSeurope_pmcdocument of 8 observations

12.8 %The prevalence of HBV was 12.8% among HIV-1 seronegative subjects in the study population in Burkina Faso.

Burkina Fasohépatite B · VIH/sidapublished 2016BMC infectious diseaseseurope_pmcdocument of 4 observations

11 %Median HBsAg prevalence was approximately 11% in female blood donors in Burkina Faso.

Burkina Fasohépatite Bpublished 2022Viruseseurope_pmcdocument of 11 observations

67 %Le taux de confirmation par qPCR des cas d'hépatite B identifiés par séquençage métagénomique était de 67 %.

Burkina Fasohépatite BHAL · Unilimdocument of 26 observations

3 %Mixed infections with HBV genotypes A3 QS and E were identified in 3% of the tested donors.

Burkina Fasohépatite Bpublished 2016Journal of medical virologyeurope_pmcdocument of 4 observations

3.3 %Among 4,520 blood donors in Burkina Faso in 2009, 149 (3.30%) had serological evidence of multiple infections.

Burkina Fasohépatite B · hépatite C · syphilis · VIH/sidaobserved 2009published 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 9 observations

99,672 participantsA total of 99,672 participants were included in the analysis of hepatitis B virus infection prevalence studies in Burkina Faso.

Burkina Fasohépatite Bpublished 2018BMC public healtheurope_pmcdocument of 12 observationsDOI 10.1186/s12889-018-5432-7

13 %In Burkina Faso, more than 13% of candidate blood donors are chronically infected with Hepatitis B virus (HBV).

Burkina Fasohépatite Bpublished 2016Journal of medical virologyeurope_pmcdocument of 4 observations

56.7 %The prevalence of HBV was 56.7% among HIV-1 positive patients in the study population in Burkina Faso.

Burkina Fasohépatite B · VIH/sidapublished 2016BMC infectious diseaseseurope_pmcdocument of 4 observations

12.8 %The prevalence of hepatitis B virus infection in Burkina Faso decreased from 12.80% between 1996 and 2001 to 11.11% between 2012 and 2017.

Burkina Fasohépatite Bobserved 1996–2001published 2018BMC public healtheurope_pmcdocument of 12 observationsDOI 10.1186/s12889-018-5432-7

72 %Among 99 HBV strains from HBsAg positive candidate blood donors in Ouagadougou, HBV genotype E had a prevalence of 72%.

Burkina Fasohépatite Bpublished 2016Journal of medical virologyeurope_pmcdocument of 4 observations

14.96 %The overall seroprevalence rate of HBV among blood donors in Burkina Faso was 14.96%.

Burkina Fasohépatite Bpublished 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 9 observations

18 %Dans le groupe d'échantillons testés pour la fièvre jaune, le virus de l'hépatite B a été détecté dans 18 % des cas du cohort mNGS et dans 28 % des cas du groupe nouvellement testé.

Burkina Fasofièvre jaune · hépatite BHAL · Unilimdocument of 26 observations

11.11 %The prevalence of hepatitis B virus infection in Burkina Faso was 11.11% between 2012 and 2017.

Burkina Fasohépatite Bobserved 2012–2017published 2018BMC public healtheurope_pmcdocument of 12 observationsDOI 10.1186/s12889-018-5432-7

The prevalence of HBV in children under 15 years old suggests potential gaps in vaccination coverage or efficacy.

Burkina Fasohépatite BHAL · Unilimdocument of 26 observations

0.11 %Among blood donors with multiple infections in Burkina Faso, the most common dual or triple combination was HBsAg-HCV-syphilis at 0.11%.

Burkina Fasohépatite B · hépatite C · syphilispublished 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 9 observations

0.66 %Among blood donors with multiple infections in Burkina Faso, the most common dual or triple combination was HBsAg-syphilis at 0.66%.

Burkina Fasohépatite B · syphilispublished 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 9 observations

11.21 %The overall prevalence of hepatitis B virus infection in Burkina Faso was 11.21%.

Burkina Fasohépatite Bpublished 2018BMC public healtheurope_pmcdocument of 12 observationsDOI 10.1186/s12889-018-5432-7

16 %Patients with non-active chronic hepatitis B represented 16.0% of the screened patients at Saint Camille Medical Centre.

Burkina Fasohépatite Bobserved 2012published 2012Pakistan journal of biological sciences : PJBSeurope_pmcdocument of 8 observations

29.82 %Among 4,520 blood donors in Burkina Faso in 2009, 1,348 (29.82%) were infected with at least one pathogen.

Burkina Fasohépatite B · hépatite C · syphilis · VIH/sidaobserved 2009published 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 9 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.